Journey Medical Corporation to Participate in September 2025 Investor Conferences

Core Insights - Journey Medical Corporation is a commercial-stage pharmaceutical company focused on FDA-approved prescription products for dermatological conditions [1][2] - The company will participate in two investor conferences in September 2025, indicating active engagement with the investment community [1][2] Company Overview - Journey Medical Corporation markets eight branded FDA-approved prescription drugs aimed at treating common skin conditions [2] - The company is based in Scottsdale, Arizona, and was founded by Fortress Biotech, Inc. [2] - Journey Medical's stock is registered under the Securities Exchange Act of 1934 and files periodic reports with the SEC [2] Upcoming Events - The company will participate in the H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025, at 1:30 p.m. ET in New York City, featuring a fireside chat and one-on-one meetings [2] - Additionally, Journey Medical will attend the Lake Street Capital Markets 9th Annual Best Ideas Growth (BIG9) Conference on September 11, 2025, also in New York City, focusing on one-on-one meetings [2]